What are the benefits and risks of drugs acting on the immune system to treat relapsing-remitting multiple sclerosis ?
There are more than 60 Cochrane Reviews relevant to multiple sclerosis and, one of these, a network meta-analysis of immunomodulators and immunosuppressants for relapsing ‐remitting multiple sclerosis, was updated in January 2024. We asked the lead author, Francesco Nonino from the Institute of Neurological Science in Bologna, Italy, to tell us more about the condition and the latest evidence in this podcast. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - March 5, 2024 Category: General Medicine Authors: Cochrane Source Type: podcasts
JAMA Neurology : Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis
Interview with Ari J. Green, MD, author of Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis. Hosted by Cynthia E. Armand, MD. Related Content: Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - November 6, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
TWiV 1055: Vermont viridae
Vincent travels to the University of Vermont to speak with Jason, Emily, Jessica, and Dimitry about their careers and their work on SARS-CoV-2, hantaviruses, poliovirus, influenza virus, and the involvement of viruses in the autoimmune disease multiple sclerosis. Host: Vincent Racaniello Guests: Jason Botten, Emily Bruce, Jessica Crothers, and Dimitry Krementsov Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode MicrobeTV Discord Server MicrobeTV store at Cafepress Spike shirts at vaccinated.us (promo code Microbetv) Research assistant position in Ros...
Source: This Week in Virology - MP3 Edition - October 22, 2023 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Cannabis and cannabinoids for people with multiple sclerosis
In May 2022, the Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group published a new review of the effects of cannabis and cannabinoids for the treatment of people with multiple sclerosis. In this podcast, Silvia Minozzi, Co-ordinating Editor of the Cochrane Drugs and Alcohol Group and an author on the review talks with lead author and Co-ordinating Editor of the Cochrane Multiple Sclerosis Group, Graziella Filippini, about the review. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - August 25, 2022 Category: General Medicine Authors: Cochrane Source Type: podcasts
Audio long-read: The quest to prevent MS — and understand other post-viral diseases
Results from a huge epidemiological study found that infection by the Epstein-Barr virus increases the risk of developing multiple sclerosis 32-fold. This result, combined with emerging mechanistic insights into how the virus triggers brain damage, are raising the prospect of treating or preventing MS.These advances come at a time when researchers are more interested than ever in what happens in the months and years following a viral infection, and highlights the issues untangling the relationships between infectious diseases and chronic conditions.This is an audio version of our Feature: The quest to prevent MS — and un...
Source: Nature Podcast - April 25, 2022 Category: Science Authors: Springer Nature Limited Source Type: podcasts
TWiV 869: Epstein-Barr virus and MS, a perfect storm
TWiV reviews epidemiological and experimental evidence that infection with Epstein-Barr virus leads to the production of antibodies against a viral protein that cross-react with a human protein, leading to multiple sclerosis. Hosts: Vincent Racaniello, Dickson Despommier, Rich Condit, and Brianne Barker Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode ABRCMS ePoster Spring Symposium for Emerging Scientists ASV Annual Meeting Registration (ASV) Microbiology & Immunology at LSU Health Viremia in human poliomyelitis (J Exp Med) EBV associated with MS (Scienc...
Source: This Week in Virology - MP3 Edition - February 20, 2022 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Baclofen for ICU Alcohol Withdrawal, Vitamin C and Thiamine for Sepsis, Multiple Sclerosis Review, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the February 23, 2021 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - February 23, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
FDA warns about rare but serious risks of stroke and blood vessel wall tears with multiple sclerosis drug Lemtrada (alemtuzumab)
(Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - December 21, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Aaron Boster, MD - Improving Outcomes in Multiple Sclerosis Through the Practice of Shared Decision-Making in Disease-Modifying Therapy Selection
Go online to PeerView.com/PPP860 to view the entire program with slides. In this activity, an expert in multiple sclerosis discusses available disease-modifying therapies and strategies for shared decision-making for patients with multiple sclerosis. Upon completion of this activity, participants should be better able to: Recognize the mechanisms of action of disease-modifying therapeutic options for patients with multiple sclerosis, Apply available data on disease-modifying therapies when managing patients with multiple sclerosis, Employ evidence-based strategies designed to facilitate shared decision-making and maintain ...
Source: PeerView CME/CE Audio Podcast - Immunology - March 13, 2019 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
FDA warns about rare but serious risks of stroke and blood vessel wall tears with multiple sclerosis drug Lemtrada (alemtuzumab)
(Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - March 5, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Barry Singer, MD - Taking Stock of Late-Breaking Data on Disease-Modifying Therapies for Multiple Sclerosis: What Are the Key Learnings From Berlin?
Taking Stock of Late-Breaking Data on Disease-Modifying Therapies for Multiple Sclerosis: What Are the Key Learnings From Berlin? (Source: Peerview CME/CE Audio Podcast - Neurology International)
Source: Peerview CME/CE Audio Podcast - Neurology International - January 23, 2019 Category: Neurology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
